Milpitas, CA, United States of America

Amy Lew Tsuhako

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 13.2

ph-index = 4

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Amy Lew Tsuhako: Innovator in Pharmaceutical Compounds

Introduction

Amy Lew Tsuhako is a prominent inventor based in Milpitas, CA (US). She has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. Her work primarily focuses on developing innovative compounds that target specific biological pathways.

Latest Patents

Among her latest patents are "Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture." This invention is directed to compounds of Formula I and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using these compounds. Another notable patent is "Pyrimidinones as casein kinase II (CK2) modulators." This patent describes a compound having Formula I or a pharmaceutically acceptable salt thereof, wherein specific variables are defined in the specification. The compounds of Formula I serve as inhibitors of Casein kinase II (CK2) pathways, showcasing her innovative approach to pharmaceutical development.

Career Highlights

Throughout her career, Amy has worked with notable companies such as Exelixis, Inc. and Symphony Evolution, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Amy has collaborated with talented individuals in her field, including Moon Jung Kim and Wei Xu. These partnerships have further enhanced her research and development efforts.

Conclusion

Amy Lew Tsuhako is a distinguished inventor whose work in pharmaceutical compounds has made a significant impact on the industry. Her innovative patents and collaborations reflect her dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…